Skip to main content
Skip to section navigation
Skip to footer
About Us
Company Overview
Team
Careers
Gene Therapies
Our Approach
Publications & Presentations
Patients
Patients & Families
Patient Spotlight
Pipeline & Programs
OPGx-BEST1
OPGx-LCA5
Preclinical
Investors
Contact Us
Back
Close menu
["https://ir.opusgtx.com/_assets/_f2acaf250c60ad9771210cfd0ac7d274/ocuphire/files/theme/site-files/20260603/js/custom.js","https://ir.opusgtx.com/_assets/_f2acaf250c60ad9771210cfd0ac7d274/ocuphire/files/theme/site-files/20260603/js/navigation-menu.js","https://ir.opusgtx.com/_assets/_f2acaf250c60ad9771210cfd0ac7d274/ocuphire/files/theme/site-files/20260603/js/navigation-menu-mobile.js","https://ir.opusgtx.com/_assets/_f2acaf250c60ad9771210cfd0ac7d274/ocuphire/files/theme/site-files/20260603/js/drawer.js"]
Skip to main content
Skip to section navigation
Skip to footer
Overview
Press Releases
Events
Presentations
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote & Chart
Historical Data
Analyst Coverage
Governance
Overview
Leadership Team
Board of Directors
Board Committees
Governance Documents
Resources
IR Contact
Email Alerts
Investor FAQs
RSS News Feed
Back to Corporate Site
Events
Investors
Investors
Overview
Press Releases
Events
Presentations
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote & Chart
Historical Data
Analyst Coverage
Governance
Overview
Leadership Team
Board of Directors
Board Committees
Governance Documents
Resources
IR Contact
Email Alerts
Investor FAQs
RSS News Feed
KOL Event
Dec 11, 2024 4:00 pm EST
Presentation
PDF
location_city
Company Profile
contact_page
Contacts
rss_feed
RSS News Feed
accessibility
Accessibility Statement